EZH2 and triple-negative breast carcinoma: In triple-negative breast cancer cells, there is a subpopulation of cells with high EZH2 expression that exhibit increased mammosphere formation and metastatic potential, and inhibition of EZH2 reduces mammosphere size and abundance [60].